Sacituzumab Govitecan: ein neues Antikörper-Wirkstoff-Konjugat für das metastasierte tripelnegative Mammakarzinom

M. Banys-Paluchowski; Natalia Krawczyk

doi:10.1007/s00761-021-00899-7

Sacituzumab Govitecan: ein neues Antikörper-Wirkstoff-Konjugat für das metastasierte tripelnegative Mammakarzinom

Translated title of the contribution: Sacituzumab govitecan: a new antibody–drug conjugate for metastatic triple-negative breast cancer

M. Banys-Paluchowski^*, Natalia Krawczyk

^*Corresponding author for this work

Clinic of Gynecology and Obstetrics

University of Düsseldorf

Translated title of the contribution	Sacituzumab govitecan: a new antibody–drug conjugate for metastatic triple-negative breast cancer
Original language	German
Journal	Onkologe
Volume	27
Issue number	3
Pages (from-to)	287-290
Number of pages	4
ISSN	0947-8965
DOIs	https://doi.org/10.1007/s00761-021-00899-7
Publication status	Published - 03.2021

Research Areas and Centers

Research Area: Luebeck Integrated Oncology Network (LION)
Centers: University Cancer Center Schleswig-Holstein (UCCSH)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00761-021-00899-7

Cite this

@article{f45ff2fd493c4e8fa1cd9a0f4bd87c7f,

title = "Sacituzumab Govitecan: ein neues Antik{\"o}rper-Wirkstoff-Konjugat f{\"u}r das metastasierte tripelnegative Mammakarzinom",

author = "M. Banys-Paluchowski and Natalia Krawczyk",

year = "2021",

month = mar,

doi = "10.1007/s00761-021-00899-7",

language = "Deutsch",

volume = "27",

pages = "287--290",

journal = "Onkologe",

issn = "0947-8965",

number = "3",

}

TY - JOUR

T1 - Sacituzumab Govitecan: ein neues Antikörper-Wirkstoff-Konjugat für das metastasierte tripelnegative Mammakarzinom

AU - Banys-Paluchowski, M.

AU - Krawczyk, Natalia

PY - 2021/3

Y1 - 2021/3

UR - http://www.scopus.com/inward/record.url?scp=85099848914&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/a80cfa31-2d02-318b-ae31-cff3fd6267c9/

U2 - 10.1007/s00761-021-00899-7

DO - 10.1007/s00761-021-00899-7

M3 - Zeitschriftenaufsätze

AN - SCOPUS:85099848914

SN - 0947-8965

VL - 27

SP - 287

EP - 290

JO - Onkologe

JF - Onkologe

IS - 3

ER -

Sacituzumab Govitecan: ein neues Antikörper-Wirkstoff-Konjugat für das metastasierte tripelnegative Mammakarzinom

Research Areas and Centers

UN SDGs

Access to Document

Other files and links

Cite this